000			02193 a2200565 4500
005			20250515042149.0
264		0	_c20070409
008			200704s 0 0 eng d
022			_a0007-1048
024	7		_a10.1111/j.1365-2141.2006.06324.x _2doi
040			_aNLM _beng _cNLM
100	1		_aRezvany, Mohammad Reza
245	0	0	_aReconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia. _h[electronic resource]
260			_bBritish journal of haematology _cNov 2006
300			_a475-85 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAlemtuzumab
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntibodies, Neoplasm _xtherapeutic use
650	0	4	_aAntigens, CD _ximmunology
650	0	4	_aAntigens, Neoplasm _ximmunology
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCD4-Positive T-Lymphocytes _xdrug effects
650	0	4	_aCD52 Antigen
650	0	4	_aCD8-Positive T-Lymphocytes _xdrug effects
650	0	4	_aComplementarity Determining Regions _xgenetics
650	0	4	_aDNA, Neoplasm _xgenetics
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGenes, T-Cell Receptor beta
650	0	4	_aGlycoproteins _ximmunology
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Variable Region _xgenetics
650	0	4	_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPilot Projects
650	0	4	_aReceptors, Antigen, T-Cell, alpha-beta _xgenetics
650	0	4	_aT-Lymphocyte Subsets _xdrug effects
700	1		_aTehrani, Mahmood Jeddi
700	1		_aKarlsson, Claes
700	1		_aLundin, Jeanette
700	1		_aRabbani, Hodjattallah
700	1		_aOsterborg, Anders
700	1		_aMellstedt, Håkan
773	0		_tBritish journal of haematology _gvol. 135 _gno. 4 _gp. 475-85
856	4	0	_uhttps://doi.org/10.1111/j.1365-2141.2006.06324.x _zAvailable from publisher's website
999			_c16574364 _d16574364